ALS is driven by a domino‑like chain reaction that begins in nerve cells, research reveals

Patients with amyotrophic lateral sclerosis (ALS), or Lou Gehrig’s disease, live an average of only three years after symptoms begin, though some can survive closer to 10 years. What drives these differences in survival has remained a mystery.

Continue Reading this article here